| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,572 |
4,794 |
$130K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
145 |
132 |
$129K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,961 |
1,870 |
$102K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
6,595 |
5,224 |
$96K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
6,578 |
5,215 |
$93K |
| 80053 |
Comprehensive metabolic panel |
24,394 |
17,301 |
$72K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
97 |
82 |
$71K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
5,245 |
3,019 |
$58K |
| 87536 |
|
1,413 |
889 |
$57K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,336 |
8,104 |
$54K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,713 |
1,194 |
$53K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
26,322 |
18,092 |
$35K |
| 87497 |
|
1,831 |
817 |
$32K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
657 |
424 |
$32K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,158 |
831 |
$28K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
221 |
163 |
$27K |
| 86480 |
|
1,260 |
1,014 |
$26K |
| 86780 |
|
5,553 |
4,645 |
$23K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
2,011 |
1,781 |
$21K |
| 83883 |
|
2,665 |
875 |
$21K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
976 |
729 |
$21K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
973 |
723 |
$21K |
| 80180 |
|
1,103 |
485 |
$20K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,023 |
5,138 |
$19K |
| 82784 |
|
2,567 |
1,497 |
$18K |
| 36415 |
Collection of venous blood by venipuncture |
15,657 |
12,079 |
$16K |
| 86235 |
|
1,446 |
548 |
$16K |
| 86334 |
|
1,512 |
814 |
$16K |
| 87799 |
|
568 |
330 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
1,596 |
1,356 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,029 |
3,929 |
$14K |
| 83970 |
|
1,035 |
885 |
$14K |
| 82607 |
|
3,981 |
3,354 |
$14K |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
399 |
139 |
$14K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,962 |
1,858 |
$13K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
562 |
408 |
$12K |
| 87522 |
Neg quan hep c or qual rna |
497 |
359 |
$11K |
| 86803 |
|
2,425 |
1,928 |
$11K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,021 |
4,346 |
$11K |
| 88112 |
|
275 |
233 |
$10K |
| 87340 |
|
3,596 |
3,003 |
$10K |
| 80197 |
|
2,698 |
1,227 |
$9K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
60 |
45 |
$9K |
| 84403 |
|
851 |
715 |
$9K |
| 85027 |
|
6,838 |
5,875 |
$8K |
| 86160 |
|
1,668 |
1,057 |
$8K |
| 90686 |
|
499 |
189 |
$8K |
| 80061 |
Lipid panel |
6,231 |
5,492 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,386 |
5,780 |
$7K |
| 83735 |
|
4,916 |
2,612 |
$7K |
| 87186 |
|
1,666 |
1,290 |
$7K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
398 |
317 |
$7K |
| 86147 |
|
751 |
556 |
$7K |
| 83615 |
|
4,800 |
2,492 |
$6K |
| 83880 |
|
1,111 |
885 |
$6K |
| 86038 |
|
1,190 |
931 |
$6K |
| 82728 |
|
4,142 |
3,456 |
$6K |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
2,961 |
2,594 |
$5K |
| 87529 |
|
198 |
128 |
$5K |
| 81001 |
|
6,949 |
5,428 |
$5K |
| 87081 |
|
2,165 |
1,949 |
$5K |
| 84153 |
|
932 |
823 |
$5K |
| 82105 |
|
871 |
707 |
$4K |
| 84165 |
|
1,660 |
944 |
$4K |
| 83516 |
|
853 |
512 |
$4K |
| 84466 |
|
1,933 |
1,574 |
$4K |
| 83540 |
|
3,463 |
2,897 |
$4K |
| 86850 |
|
2,986 |
2,350 |
$4K |
| 86704 |
|
1,166 |
897 |
$4K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
181 |
140 |
$4K |
| 82746 |
|
1,658 |
1,402 |
$4K |
| 83001 |
|
589 |
507 |
$4K |
| 86225 |
|
1,226 |
977 |
$4K |
| 86706 |
|
1,181 |
931 |
$4K |
| 86140 |
|
3,369 |
2,333 |
$4K |
| 86360 |
|
1,231 |
794 |
$4K |
| 84439 |
|
2,596 |
2,278 |
$3K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
446 |
391 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
546 |
506 |
$3K |
| 87517 |
|
137 |
106 |
$3K |
| 86901 |
|
3,144 |
2,426 |
$3K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
30 |
27 |
$3K |
| 87220 |
|
2,787 |
2,398 |
$3K |
| 80076 |
|
1,396 |
1,184 |
$3K |
| 84550 |
|
3,263 |
1,705 |
$3K |
| 87210 |
|
2,738 |
2,354 |
$3K |
| 84100 |
|
2,933 |
1,415 |
$3K |
| 99201 |
|
147 |
82 |
$3K |
| 80069 |
|
1,300 |
935 |
$3K |
| 86787 |
|
528 |
411 |
$3K |
| 86359 |
|
1,234 |
799 |
$3K |
| 87205 |
|
3,689 |
3,124 |
$3K |
| 85610 |
|
3,599 |
2,550 |
$3K |
| 84702 |
|
1,016 |
726 |
$3K |
| 83550 |
|
1,522 |
1,295 |
$3K |
| 82232 |
|
1,228 |
620 |
$2K |
| 86900 |
|
3,150 |
2,422 |
$2K |
| 82570 |
|
2,089 |
1,560 |
$2K |
| 95800 |
|
29 |
28 |
$2K |
| 86039 |
|
837 |
667 |
$2K |
| 87077 |
|
1,048 |
768 |
$2K |
| 86762 |
|
1,362 |
1,192 |
$2K |
| 84146 |
|
579 |
500 |
$2K |
| 87088 |
|
609 |
553 |
$2K |
| 83520 |
|
357 |
263 |
$2K |
| 86790 |
|
325 |
222 |
$2K |
| 82670 |
|
567 |
377 |
$2K |
| 87070 |
|
1,081 |
867 |
$2K |
| 86769 |
|
57 |
38 |
$2K |
| 81268 |
|
19 |
12 |
$2K |
| 82951 |
|
271 |
247 |
$1K |
| 87493 |
|
74 |
69 |
$1K |
| 83020 |
|
577 |
542 |
$1K |
| 85652 |
|
2,392 |
1,958 |
$1K |
| 85730 |
|
880 |
672 |
$1K |
| 82378 |
|
248 |
219 |
$1K |
| 87075 |
|
231 |
197 |
$1K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$1K |
| 82550 |
|
747 |
577 |
$1K |
| 82950 |
|
1,056 |
968 |
$1K |
| 81267 |
|
32 |
12 |
$1K |
| 84480 |
|
633 |
543 |
$1K |
| 82043 |
|
1,174 |
1,049 |
$1K |
| 84156 |
|
2,042 |
1,513 |
$993.72 |
| G0008 |
Administration of influenza virus vaccine |
294 |
140 |
$984.63 |
| 83690 |
|
558 |
407 |
$922.23 |
| 86256 |
|
295 |
240 |
$846.24 |
| 87184 |
|
282 |
241 |
$804.64 |
| 84402 |
|
189 |
164 |
$779.40 |
| 83002 |
|
341 |
285 |
$778.47 |
| 86592 |
|
695 |
468 |
$773.33 |
| 86765 |
|
465 |
424 |
$763.74 |
| 86304 |
|
90 |
80 |
$745.58 |
| 84481 |
|
339 |
295 |
$718.15 |
| 82565 |
|
519 |
415 |
$712.72 |
| 86431 |
|
442 |
375 |
$704.70 |
| 73630 |
|
84 |
62 |
$670.68 |
| 86146 |
|
18 |
13 |
$659.94 |
| 86200 |
|
237 |
209 |
$657.14 |
| 84425 |
|
136 |
111 |
$647.99 |
| 86317 |
|
91 |
39 |
$589.00 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14 |
12 |
$535.12 |
| 87486 |
|
60 |
45 |
$512.45 |
| 87581 |
|
60 |
45 |
$490.16 |
| 86800 |
|
204 |
172 |
$448.23 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
78 |
51 |
$440.60 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
19 |
13 |
$435.01 |
| 85045 |
|
708 |
540 |
$404.79 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
19 |
18 |
$402.96 |
| 82533 |
|
114 |
93 |
$402.65 |
| 86255 |
|
142 |
102 |
$357.50 |
| 77077 |
|
12 |
12 |
$344.06 |
| 88342 |
|
52 |
42 |
$296.01 |
| 86644 |
|
61 |
36 |
$292.04 |
| 84630 |
|
127 |
107 |
$282.10 |
| 82248 |
|
279 |
199 |
$275.96 |
| 82150 |
|
171 |
103 |
$268.31 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
26 |
26 |
$221.20 |
| 87045 |
|
76 |
72 |
$193.58 |
| 72100 |
|
13 |
12 |
$169.09 |
| 85379 |
|
91 |
66 |
$165.89 |
| 87338 |
|
18 |
12 |
$164.09 |
| 73030 |
|
16 |
12 |
$141.62 |
| 81003 |
|
221 |
171 |
$140.28 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
18 |
12 |
$130.14 |
| 80177 |
|
57 |
54 |
$121.68 |
| 84154 |
|
20 |
12 |
$116.10 |
| 86665 |
|
13 |
12 |
$112.60 |
| 82952 |
|
150 |
143 |
$95.70 |
| 84681 |
|
19 |
13 |
$87.36 |
| 84703 |
|
51 |
42 |
$87.02 |
| 82040 |
|
63 |
50 |
$79.98 |
| 85007 |
|
112 |
72 |
$67.94 |
| 87177 |
|
52 |
50 |
$63.72 |
| 86677 |
|
15 |
14 |
$59.20 |
| 85651 |
|
35 |
27 |
$52.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
76 |
36 |
$48.50 |
| 87102 |
|
17 |
13 |
$36.24 |
| 81025 |
|
17 |
12 |
$35.30 |
| 87046 |
|
76 |
72 |
$31.98 |
| 87206 |
|
40 |
30 |
$30.60 |
| 82390 |
|
15 |
12 |
$30.17 |
| 86709 |
|
13 |
12 |
$19.04 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
159 |
133 |
$7.81 |